Cargando…

Immunophenotype and antitumor activity of cytokine-induced killer cells from patients with hepatocellular carcinoma

BACKGROUND: Cytokine-induced killer (CIK) cells are heterogeneous lymphocytes from human peripheral blood mononucleated cells (PBMCs) co-cultured with several cytokines. The main purpose of this study is to evaluate the functional characteristics and anticancer ability of CIK cells from hepatocarcin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chan-Keng, Huang, Chien-Hao, Hu, Ching-Hsun, Fang, Jian-He, Chen, Tse-Ching, Lin, Yung-Chang, Lin, Chun-Yen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812323/ https://www.ncbi.nlm.nih.gov/pubmed/36598909 http://dx.doi.org/10.1371/journal.pone.0280023

Ejemplares similares

NaHCO(3) enhances the antitumor activities of cytokine-induced killer cells against hepatocellular carcinoma HepG2 cells
por: Yuan, Ya Hong, et al.
Publicado: (2016)

Antitumor Effect of Periplocin in TRAIL-Resistant Human Hepatocellular Carcinoma Cells through Downregulation of IAPs
por: Cheng, Chieh-Fang, et al.
Publicado: (2013)

Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety
por: Ma, Yue, et al.
Publicado: (2012)

Cytokine-induced killer cells promote antitumor immunity
por: Jiang, Jingting, et al.
Publicado: (2013)

Molecular subtypes based on DNA sensors predict prognosis and tumor immunophenotype in hepatocellular carcinoma
por: Lin, Hong-Sheng, et al.
Publicado: (2023)

Immunophenotype Expressions and Cytokine Profiles of Influenza A H1N1 Virus Infection in Pediatric Patients in 2009
por: Wang, Shih-Min, et al.
Publicado: (2014)

Antitumor effect of kurarinone and underlying mechanism in small cell lung carcinoma cells
por: Chung, Ting-Wen, et al.
Publicado: (2019)

The Combined Antitumor Effects of (125)I Radioactive Particle Implantation and Cytokine-Induced Killer Cell Therapy on Xenograft Hepatocellular Carcinoma in a Mouse Model
por: Zhang, Junyong, et al.
Publicado: (2017)

Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus
por: Zhao, Xing, et al.
Publicado: (2017)

Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells
por: WANG, YULIANG, et al.
Publicado: (2015)

Hepatocellular carcinoma in hemodialysis patients
por: Lee, Chern-Horng, et al.
Publicado: (2017)

Liraglutide activates nature killer cell-mediated antitumor responses by inhibiting IL-6/STAT3 signaling in hepatocellular carcinoma
por: Lu, Xian, et al.
Publicado: (2020)

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis
por: Yuan, Xin, et al.
Publicado: (2021)

Correction: Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus
por: Zhao, Xing, et al.
Publicado: (2018)

A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma
por: Pan, Qiu-Zhong, et al.
Publicado: (2015)

Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
por: Cao, Jing, et al.
Publicado: (2019)

Role of Immunophenotypes in Carcinoma Breast
por: Shukla, Samarth, et al.
Publicado: (2018)

Immunophenotyping of pulmonary sarcomatoid carcinoma
por: Ma, Yu, et al.
Publicado: (2022)

Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas
por: Zhang, Qi, et al.
Publicado: (2019)

Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review
por: Cai, Xiu-Rong, et al.
Publicado: (2017)

CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection
por: Yeh, Chau-Ting, et al.
Publicado: (2009)

Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognition
por: Rong, Xiao-Xiang, et al.
Publicado: (2015)

Therapeutic Role of Inducible Nitric Oxide Synthase Expressing Myeloid-Derived Suppressor Cells in Acetaminophen-Induced Murine Liver Failure
por: Hsu, Chen-Yu, et al.
Publicado: (2020)

Increase of Antitumoral Effects of Cytokine-Induced Killer Cells by Antibody-Mediated Inhibition of MICA Shedding
por: Wu, Xiaolong, et al.
Publicado: (2020)

Polyploidy Spectrum Correlates with Immunophenotype and Shapes Hepatocellular Carcinoma Recurrence Following Liver Transplantation
por: Zhang, Liang, et al.
Publicado: (2022)

Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection
por: Chen, Jian-Lin, et al.
Publicado: (2016)

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma
por: Yu, Chun-Yen, et al.
Publicado: (2023)

Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma
por: Huang, Song-Fong, et al.
Publicado: (2022)

Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication
por: Lu, Ming-Ying, et al.
Publicado: (2022)

Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells
por: Chiu, Chien-Ming, et al.
Publicado: (2018)

Radiomic Immunophenotyping of GSEA-Assessed Immunophenotypes of Glioblastoma and Its Implications for Prognosis: A Feasibility Study
por: Hsu, Justin Bo-Kai, et al.
Publicado: (2020)

Immunophenotype
por: Albani, Salvatore
Publicado: (2014)

The Eltrombopag antitumor effect on hepatocellular carcinoma
por: KUROKAWA, TOMOHIRO, et al.
Publicado: (2015)

Antitumoral effect of Ocoxin in hepatocellular carcinoma
por: Díaz-Rodríguez, Elena, et al.
Publicado: (2017)

Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapy
por: Hu, Ching-Chih, et al.
Publicado: (2018)

Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver
por: Nakashima, Hiroyuki, et al.
Publicado: (2023)

The role of p21-activated kinases in hepatocellular carcinoma metastasis
por: Tse, Edith Yuk Ting, et al.
Publicado: (2014)

The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy
por: Tsai, Ming-Chao, et al.
Publicado: (2021)

Cost-Effectiveness of Adjuvant Immunotherapy With Cytokine-Induced Killer Cell for Hepatocellular Carcinoma Based on a Randomized Controlled Trial and Real-World Data
por: Cho, Jeong-Yeon, et al.
Publicado: (2021)

Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell–Mediated Antitumor Immunity Through PD‐L1
por: Chui, Noreen Nog‐Qin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2qobns59k3utq79spqmk01rqff